Search results
Results From The WOW.Com Content Network
Sanofi S.A. is a French multinational pharmaceutical and healthcare company headquartered in Paris, France. The corporation was established in 1973 and merged with Synthélabo in 1999 to form Sanofi-Synthélabo. In 2004, Sanofi-Synthélabo merged with Aventis and renamed to Sanofi-Aventis, which were each the product of several previous mergers ...
The following are list of bioCSL flu vaccine brands: [31] Trivalent. Afluria, also marketed as Enzira, Fluvax, and Nilgrip in various different markets. Agrippal, also marketed as Begripal, Fluazur, Sandovac, Agriflu, and Chiroflu in various different markets. Fluad, [32] [1] also marketed as Chiromas in Spain.
This listing is limited to those independent companies and subsidiaries notable enough to have their own articles in Wikipedia. Both going concerns and defunct firms are included, as well as firms that were part of the pharmaceutical industry at some time in their existence, provided they were engaged in the production of human (as opposed to veterinary) therapeutics.
Sanofi-Aventis's second announcement today also shows a strategy shift. ... ARQ 197, improved by 66% the median progression-free survival (PFS) of patients with advanced non-small-cell lung cancer ...
Sanofi Pasteur. Sanofi Pasteur is the vaccines division of the French multinational pharmaceutical company Sanofi. Sanofi Pasteur is the largest company in the world devoted entirely to vaccines. It is one of four global producers of the yellow fever vaccine.
Sanofi-Aventis (SNY) shares are up nearly 2% in early morning trading after it announced it entered into a global, strategic alliance with Regulus Therapeutics to discover, develop, and ...
French pharmaceutical company Sanofi-Aventis (SNY), which has been unsuccessful in its recent courtship of U.S. biotech giant Genzyme (GENZ), announced Thursday it signed a 10-year agreement with ...
On March 9, 2010, Sanofi-Aventis announced [6] it had exercised an option to combine Merial with Intervet/Schering Plough, the animal health business of Merck. The new joint venture would be equally owned by Merck and Sanofi-Aventis. On March 22, 2011, they announced the mutual termination of their agreement to form a new animal health joint ...